Skip to main content
Premium Trial:

Request an Annual Quote

In Vivo Study Suggests Potential Efficacy of Proteome Sciences' Anti-Alzheimer's CK1D Inhibitors

Premium

Proteome Sciences said this week that it has completed an in vivo study of its CK1D-inhibitor Alzheimer's disease therapy, finding that both of its lead compounds improved cognitive function in animal models.

The company now plans to begin a "comprehensive assessment of biological indicators and drug levels in various tissues," it said in a statement.

The recently completed study follows on an effort earlier last year in which Proteome Sciences demonstrated that its CK1D inhibitors – PS110 and PS278 – block tau phosphorylation in cell lines (PM 8/10/2012).

Ultimately, the company aims to partner with an established pharmaceutical company to commercialize the compounds.

The drug program stems from work the company did in collaboration with researchers at Kings College, London, on using mass spec to map post-translational modifications on tau. Through this work, the company identified a number of previously undetected tau phosphorylation sites, many of them regulated by CK1D – suggesting its potential suitability as a drug target.

Over the last two years, the company has been using in silico modeling along with its pTau 2.0 & 3.0 selected-reaction monitoring mass spec assays for tau phosphorylation to profile potential inhibitors of the protein.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.